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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYHematopoietic stem cells (HSC), the self-renewing cells of the adult blood differentiation hierarchy, are generated during embryonic
stages. The first HSCs are produced in the aorta-gonad-mesonephros (AGM) region of the embryo through endothelial to a hematopoietic
transition. BMP4 and Hedgehog affect their production and expansion, but it is unknown whether they act to affect the same HSCs. In
this study using the BRE GFP reporter mouse strain that identifies BMP/Smad-activated cells, we find that the AGM harbors two types
of adult-repopulating HSCs upon explant culture: One type is BMP-activated and the other is a non-BMP-activated HSC type that is
indirectly controlled by Hedgehog signaling through the VEGF pathway. Transcriptomic analyses demonstrate that the two HSC types
express distinct but overlapping genetic programs. These results revealing the bifurcation in HSC types at early embryonic stages in the
AGM explant model suggest that their development is dependent upon the signaling molecules in the microenvironment.INTRODUCTION
The first definitive long-term repopulating hematopoietic
stem cells (HSCs) originate in the aorta-gonad-meso-
nephros (AGM) region at mouse embryonic day 10.5
(E10.5) (Medvinsky and Dzierzak, 1996) and emerge from
hemogenic endothelial cells lining the aorta and other ar-
teries through endothelial to hematopoietic transition (Jaf-
fredo et al., 1998; de Bruijn et al., 2002; North et al., 2002;
Zovein et al., 2008; Chen et al., 2009; Boisset et al., 2010).
HSCs are found in hematopoietic clusters closely associated
with the vasculature and are in an exclusively ventral posi-
tion in the aorta (Taoudi and Medvinsky, 2007), high-
lighting the importance of positional information within
the growing embryo. Indeed, in avian embryos ventraliz-
ing factors such as vascular endothelial growth factor
(VEGF), bone morphogenetic protein 4 (BMP4), basic
fibroblast growth factor (bFGF), and transforming growth
factor b (TGF-b) are hematopoietic cell inductive, whereas
dorsalizing factors such as epidermal growth factor and
TGF-a are inhibitors (Pardanaud and Dieterlen-Lievre,
1999). After their generation, HSCs colonize other hemato-
poietic sites including the fetal liver (FL), where they are
greatly expanded (Medvinsky and Dzierzak, 1996; Ema
and Nakauchi, 2000; Kumaravelu et al., 2002; Gekas
et al., 2005). HSCs migrate again just before birth and colo-
nize the bone marrow (BM) where they reside throughoutStemadult life in endothelial and osteoblastic niches (Mendel-
son and Frenette, 2014). Thus, the establishment of
the vertebrate hematopoietic system is a temporally and
spatially controlled ontogenic process that depends on
inducing factors and/or growth factors in the different
developmental niches.
A key factor in hematopoietic development is BMP4,
which is required during different embryonic stages, begin-
ning at the time of gastrulation and mesoderm formation
(Winnier et al., 1995) and playing a central role in the
hematopoietic specification of mesodermal cells (Zhao,
2003; Pearson et al., 2008). Mice lacking Bmp4 die in utero
before the onset of blood formation. Loss of Bmp4 endows
the embryo with ‘‘dorsalized’’ characteristics and decreases
the ventral lineages including hematopoietic cells, vessels,
and the pronephric kidney. In contrast, an increase in the
ventral lineages is observed when Bmp4 is overexpressed
(Gupta et al., 2006). Similar effects of BMP4 are observed
in Xenopus, and in zebrafish ventrally localized Bmp4 in-
duces the blood stem cell program in the dorsal aorta (Wil-
kinson et al., 2009; Huber et al., 1998). In the mouse and
human AGM region, ventrally localized BMP4 expression
in the endothelial and mesenchymal cells underlying
the emerging hematopoietic cluster cells (Marshall et al.,
2000; Durand et al., 2007) is thought to influence HSC
generation. Indeed, BMP4 increases HSC activity in mouse
AGM explants and reaggregates (Durand et al., 2007; KimCell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The Authors 383
et al., 2015). Moreover, all AGMHSCs in vivo are BMP acti-
vated (Crisan et al., 2015).
Another developmental regulator,Hedgehog (Hh), acts as
a morphogen in many developing tissues. Visceral endo-
derm is instructive to the development of endothelial and
hematopoietic cells through Hh signaling early in mouse
gastrulation (Belaoussoff et al., 1998; Dyer et al., 2001).
Hh protein can replace endodermal tissue (gut) to induce
HSCs in AGM explant cultures before the normal onset of
HSCgeneration (Peeters et al., 2009). ZebrafishHhpathway
mutants display significant defects in HSC formation, and
Hh factors act upstream of VEGF to regulate definitive
hematopoiesis in the embryo (Gering and Patient, 2005).
Although BMP4 and Hh, when studied individually,
have been shown to influence HSC growth, it is unknown
whether these signaling pathways intersect in the same
HSCs. In this study, we make use of BMP Responsive
Element (BRE) GFP transgenic mice to study the BMP
signaling pathway and the effects of Hh simultaneously
on AGM HSC development. We show in explant cultures
that the AGM contains two types of HSCs, BMP-activated
and non-BMP-activated HSCs, with distinct but overlap-
ping genetic programs. The non-BMP-activated HSC type
is lost when the Hh signaling pathway is inhibited, but
can be partially rescued by VEGF. We reveal here the
signaling pathway regulation involved in the bifurcation
of HSC types during development.RESULTS
BMP and Hedgehog Factors Affect HSC Activity in
Serum-Free AGM Explants
Although BMP4 and Hedgehog factors individually influ-
ence HSC growth, it is unknown whether these signaling
pathways intersect to control HSCs. To address this ques-
tion, we used AGM explant culture (AGMex) as a tractable
system bywhich the specific effect of BMP4 or Shh individ-
ually, or in combination, on HSCs could be examined. E11
AGM explants were cultured for 3 days in serum-free
medium to eliminate the contribution of growth factors
known to be present in serum. When tested by transplan-
tation into irradiated adult recipients, no HSCs were found
in the AGMex in the absence of serum (none repopulated of
six transplanted recipients) compared with 40% of recipi-
ents repopulated (two of five) with HSCs from AGMex in
medium containing serum (Figure 1A). When BMP4 or
Shh were added to serum-free AGMex, 33% of transplanted
mice (two repopulated of six transplanted) were high-level,
long-term reconstituted (Figure 1A), thus suggesting that
individually, BMP4 and Shh have a positive effect on
AGM HSC activity. When BMP4 and Shh were added
together, 83% of transplanted mice were reconstituted384 Stem Cell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The Autho(five repopulated of six transplanted), with the average
level of donor chimerism (36%). In combination, BMP4
and Shh significantly improve HSC activity (p = 0.0005)
compared with no factors in serum-free AGMex, and the
level of HSC activity is similar to that obtained in recipients
transplanted with AGMex in serum-containing medium
(40%). Although the combined addition of factors did
not yield a significant increase in HSC activity when
compared with the single factor additions, this trend sug-
gests that they may control different HSCs.
The AGMContains Two HSC Types in Explant Culture
Tomore specifically investigate the distinct or combined ef-
fects of BMP and Hh factors on HSC activity in AGMex, we
used the BRE GFP transgenic reporter mouse model (Mon-
teiro et al., 2008). In these mice GFP expression reports
those cells that, at the time of isolation, are activated by
BMP. Recently we showed that this model allows the isola-
tion of HSCs based on their BMP-activation status (Crisan
et al., 2015). Our data showed that all AGM HSCs in vivo
(AGMin) are BMP activated whereas at later ontogenic
stages in vivo (in the E14 FL and adult BM), two distinct
HSC types exist: BMP activated and non-BMP activated
(Crisan et al., 2015).
Surprisingly, when E11 AGM explants from BRE GFP
transgenic embryos were cultured for 3 days in serum-
containing medium followed by transplantation of GFP+
and GFP sorted cells into irradiated adult mice, HSCs
were found in both fractions (Figure 1B). Six out of seven
recipients receiving GFP+ and three out of five recipients
receiving GFP AGMex cells were high-level, multilineage
engrafted at 4 months post transplantation. These HSCs
were self-renewing, as shown by secondary transplanta-
tions (Figure S1). Thus, in contrast to AGMin, the explant
culture of the AGM reveals the existence of two HSC types:
BMP activated and non-BMP activated.
Non-BMP-Activated AGMex HSCs Are Controlled by
Hh/VEGF
We sought to examine whether Hh influences both of
the AGMex HSC types. To test this, we added the Hh
pathway inhibitor cyclopamine to BRE GFPAGM explants.
Following 3 days of culture, GFP+ and GFP cells were
sorted and transplanted (Figure 1B). No effect was observed
on long-term repopulation by GFP+ HSCs from AGMex in
the presence of cyclopamine. These HSCs provided the
same high-level, multilineage engraftment as in the
absence of cyclopamine. In contrast, all HSC activity was
lost (none of four) in the GFP fraction and almost reached
significance (p = 0.06) when theHhpathwaywas inhibited,
compared with the AGMex GFP control (three of five).
Since HSCs in zebrafish embryos are controlled by VEGF
downstream of the Hh pathway (Gering and Patient,rs
Figure 1. The AGM Contains Two HSC Types in Explant Culture
(A) Percentage donor cell chimerism in peripheral blood (PB) of adult irradiated transplant recipients at 4 months after injection of
unsorted cells from E11 AGM explants (AGMex) cultured in serum-containing (+) or serum-free () medium with BMP4 and/or Shh, as
shown below the graph. On to three AGM embryo equivalents (ee) were transplanted per recipient (n = 2 or 5; 1 or 4 mice transplanted/
experiment). See Table S2. Each dot represents one recipient mouse. p = 0.0005 by z test for proportions.
(B) Percentage donor cell chimerism in the PB of adult irradiated transplant recipients at 4 months after injection of E11 AGMex BRE GFP+
(+) or BRE GFP () cells (2–4 ee transplanted/recipient; 1 or 2 mice transplanted/experiment; n = 7, 4, or 3). See Table S2. Culture
conditions with cyclopamine and/or VEGF are indicated below the graph. p = 0.06 and p = 0.02 by z test for proportions. For (A) and (B),
positive repopulation was considered to be >5% chimerism, as denoted by the gray dashed line.
(C) qRT-PCR results for Ihh, Gli1, and Vegf expression in unsorted cells from AGMin (white bars) and AGMex (black bars). Error bars
show ±SEM, with p value by t test (n = 3).
(D) Gli1 transcript levels (FPKMs) in AGM cell fractions as detected by RNA sequencing. E11 AGM BRE GFP hematopoietic progenitor/stem
cells (HPSC; CD31+cKit+), endothelial cells (EC, CD31+cKit), and ‘‘other’’ non-HPSC, non-EC cells (OC; CD31) were sorted by flow cytometry
into GFP+ and GFP fractions from AGMin (white bars), AGMex (black bars), and AGMex,cyclopamine (gray bars).2005), we next tested whether VEGF could rescue the GFP
HSCs in cyclopamine-treated AGMex. Remarkably, exoge-
nous VEGF partially restored GFP HSC activity in cyclop-
amine-containing AGMex. Three out of four transplanted
recipients were repopulated, although with a lower
chimerism level (19%) compared with the control (56%)
(p = 0.02; Figure 1B).StemqRT-PCR revealed that transcripts for Ihh, Gli1, and Vegf
were increased 4.7-fold (p = 0.03), 2.5-fold (p = 0.02), and
3.5-fold (p = 0.002), respectively in AGMex compared
with AGMin, further supporting the active nature of these
signaling pathways in the explant culture (Figure 1C).
Interestingly, RNA sequencing data from sorted GFP+
and GFP cells in the hematopoietic progenitor/stem cellCell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The Authors 385
Figure 2. Cell Lineage Distribution of GFP+ and GFP Cells in E11 BRE GFP AGMin and AGMex
(A–D) Representative FACS plots showing percentages of HPSC (CD31+cKit+), EC (CD31+cKit), and OC (CD31) within the GFP+ and GFP
fractions (A) in vivo AGM (AGMin) and (C) AGM explants (AGMex). The absolute number of each cell lineage per E11 AGMin (B) and AGMex (D)
in GFP+ (dark gray) and GFP (light gray) fractions are compared. (B, n = 6; D, n = 5). Error bars show ±SEM, with p value by t test.
(legend continued on next page)
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(HPSC) (CD31+cKit+), endothelial cell (EC; CD31+cKit).
and ‘‘other cell’’ (OC; CD31cKit) fractions show that
Gli1 FPKMs (fragments per kilobase of transcript per
million mapped reads) are dramatically increased in the
non-BMP-activated (GFP) AGMex EC when compared
with AGMin EC (Figure 1D). This upregulation is not found
when cyclopamine is added. In general,Gli1 FPKMs are low
in the HPSC. The OC fraction shows high levels of Gli1
expression before and after explant that is only slightly
decreased in the presence of cyclopamine. Together, these
data demonstrate that Hh signaling affects non-BMP-acti-
vated AGMex HSCs most likely through ECs, with VEGF
acting downstream of the Hh pathway activation to con-
trol these HSCs.
The AGMex Microenvironment Allows the
Development of the Two HPSC Types
The cellular composition of BRE GFP AGMex compared
with AGMin was examined by flow cytometric analysis.
In AGMin, phenotypic HPSCs are present in both fractions
and in absolute number are slightly more abundant (1.7-
fold) in the GFP fraction (p = 0.03) (Figures 2A and 2B).
HPSCs are found also in both GFP+ and GFP AGMex frac-
tions (Figure 2C). In absolute number, the AGMex contains
5.7-fold (p = 0.002) more GFP+ HPSCs than the AGMin,
while the number of GFPHPSCs shows little to no change
upon culture (Figure 2D). Close examination of intra-aortic
hematopoietic clusters by multimarker confocal imaging
confirms the presence of GFP+ (arrowhead) and GFP (ar-
row) phenotypic HPSCs (Figure 2E). Indeed, when AGMin
cells were tested by in vitro colony-forming unit culture
(CFU-C) assay, both the GFP+ and GFP HPSC fractions
contained hematopoietic progenitors (HPCs), indicating
that heterogeneity for BMP-activation status already exists
at this stage in vivo (Figure 2F).
Similarly, EC andOC are detected in bothGFP+ andGFP
AGMin fractions (Figure 2A). ECs are equally distributed be-
tween the GFP+ andGFP fractions and the OC non-HPSC/
non-EC population ismostly GFP (p = 0.0001) (Figure 2B).
After explant, most ECs (p = 0.0002) and OCs (p = 0.006)
are BMP activated (Figure 2D) and are significantly
increased in the absolute number of GFP+ cells (3.7- and
16.0-fold, respectively) (Figure 2G), suggesting that some
GFP cells become responsive to BMP and some BMP-acti-
vated cells expand. These component changes in AGMex(E) High-magnification image of an immunostained E11 BRE GFP aortic
a GFP+ and arrow indicates a GFP hematopoietic cluster cell in vivo
(F) The number of hematopoietic progenitors found in the GFP+ (dar
sorted cells (n = 3). Error bars show ±SEM. No differences as measure
(G) Fold increase of E11 AGM HPSC, EC, and OC number in the GFP+ an
Student’s t test.
Stemcompared with AGMin may provide specific microenviron-
ments for the development of the two HSC types.
AGMex GFP+ Cells Give Rise to GFP HSCs
Since the in vivo E11 AGMcontains exclusivelyGFP+HSCs,
we hypothesized that the GFPHSCs in AGMex are derived
from GFP+ HSCs. To test this, we performed secondary
transplantations. BM cells from primary recipient mice
that were high-level reconstituted with GFP+ or GFP
AGMex cells were sorted into GFP+ and GFP fractions and
injected into adult irradiated secondary recipients (Fig-
ure 3). Both GFP+ and GFP BM fractions from primary
mice reconstituted with GFP+ AGMex HSCs provided long-
term, high-level hematopoietic chimerism. In contrast,
when primary recipient mice that were high-level reconsti-
tuted with GFPAGMex cells were analyzed, no to very few
GFP+ cells were found in the BM. Unsorted BM (containing
GFP HSCs) was able to provide long-term, high-level
hematopoietic chimerism in secondary recipients. These
data show that following HSC induction in the AGM,
someGFP+ AGMHSCs remainBMP activated and somepre-
viously BMP-activated HSCs are no longer responsive to
BMP signaling in the recipient BM microenvironment,
thus becoming non-BMP-activated HSCs. Non-BMP-acti-
vatedHSCs remain inanon-activated state in the secondary
recipients. Together, these data indicate a one-directional
transition of BMP-activated AGMHSCs to a non-BMP-acti-
vated state in the BMmicroenvironment.
Transcriptome Differences between BMP-Activated
and Non-BMP-Activated AGM HPSCs
The molecular programs intrinsic to the BMP-activated
(GFP+) and non-BMP-activated (GFP) AGMex HPSC popu-
lations were examined by RNA sequencing. Gene ontology
(GO) analysis of genes with >2-fold increased expression
level in GFP+ HPSCs shows significant enrichment of extra-
cellular matrix (ECM) organization, signaling pathway,
blood vessel/angiogenesis, and cell adhesion genes (Fig-
ure 4A). GO terms for immune response, cell cycle, meta-
bolism, and transcription were found to be significantly
upregulated in the GFP HPSC fraction (Figure 4B).
Furthermore, gene sets with TCF3, SOX9, NRIP1, Zfx,
and CCND1 upregulated genes were significantly upregu-
lated in the BMP-activated HPSCs, while gene sets of the
downregulated genes were significantly upregulated incluster (CD31, magenta; cKit, red; GFP, green). Arrowhead indicates
(AGMin).
k gray) and GFP (light gray) fractions of E11 AGMin CD31and cKit
d by Student’s t test.
d GFP fractions upon culture (ex/in). Significance determined by
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Figure 3. GFP+ AGMex Cells Give Rise to
GFP HSCs
Strategy and secondary transplantation re-
sults of GFP+ and GFP sorted BM cells from
reconstituted primary recipients of Fig-
ure 1B, injected with E11 BRE GFP AGM
explant (AGMex) cells. At 4 months post
injection, five of six and four of six sec-
ondary recipient mice were high-level re-
constituted with GFP and GFP+ fractions,
respectively, from primary recipients
receiving GFP+ AGMex cells (n = 2; 3 mice
transplanted/experiment). See Table S2. No
or few GFP+ cells were detected in the BM
of primary recipients transplanted with
GFP AGMex cells (unsorted BM yielded re-
population). Peripheral blood (PB) chime-
rism of primary and secondary recipients at
4 months post transplantation is shown.the non-BMP-activated HPSCs (Figure 4C). Most of these
genes are abnormal in different types of leukemia—TCF3
and NRIP1 in lymphoblastic leukemia (Hartsink-Segers
et al., 2015; Lapierre et al., 2015; Somasundaram et al.,
2015), CCND1 in chronic myeloid leukemia (Gerber
et al., 2013), Sox9 in promyelocytic leukemia (Djouad
et al., 2014), and Zfx, a component transcription factor of
LIF and BMP signaling pathways, in HSCs (Galan-Caridad
et al., 2007; Chen et al., 2008). Gene list enrichment anal-
ysis further shows that gene sets with NIPBL, SALL4, and
Suz12 upregulated genes were significantly upregulated in
the non-BMP-activated HPSCs while their downregulated
target genes were significantly upregulated in BMP-acti-
vated HPSCs, suggesting a possible role in the regulation
of non-BMP-activated HPSCs (Figure 4D). NIPBL is a part-
ner of the ETV6 transcription factor in acute megakaryo-
blastic leukemia (Kuleszewicz et al., 2013; de Braekeleer
et al., 2013), and Sall4 is constitutively active in acute
myeloid leukemia (Ma et al., 2006; Zhang et al., 2015).
Transcripts of key HSC transcription factors such as
Runx1, Gata2, Lmo2, Fli1, Etv6, and Gfi1b were found in
both HPSC fractions, before and after explant, although
at varying levels (Figure 5A). The transcription factors
Sox17, required for endothelial to hematopoietic cell tran-
sition (Clarke et al., 2013), and Erg, required for definitive
hematopoiesis (Loughran et al., 2008), were highly specific
for BMP-activated HSCs, as no/low transcripts were found
in the non-BMP-activated HSCs in both AGMin and
AGMex. In contrast, hematopoietic cell marker genes ckit,
Itga2b, and Ptprc, although expressed in both fractions,
were higher in the non-BMP-activated AGMex HPSCs
CD93 (AA4.1), and CD34 was more highly expressed in
the BMP-activated HPSCs (Figure 5B). Genes of typical
endothelial markers Pecam 1 (CD31), Cdh5 (VE-cadherin),388 Stem Cell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The AuthoEng (endoglin, CD105), Tek (Tie-2), and wWF (von Wille-
brand factor) were more highly expressed in the BMP-acti-
vated HPSCs compared with non-BMP-activated HPSCs
suggesting their hemogenic endothelial origin (Figure 5C).
These observations are consistent with data demonstrating
that all HSCs in vivo express VE-cadherin at the time of
their generation (Chen et al., 2009) and that endoglin ini-
tiates hematopoietic commitment from the mesoderm by
activating the BMP pathway (Borges et al., 2012). Dendro-
gramanalysis shows thatHPSCs are closer toGFP+ ECs than
to GFP ECs in both AGMin and AGMex (Figure 5D), sug-
gesting that the hemogenic endothelium is also BMP acti-
vated. Thus, based on transcriptome data, BMP-activated
HPSCs express a more hemogenic endothelial molecular
program, whereas the non-BMP-activated HPSC program
is highly hematopoietic.
Since the non-BMP-activated HSCs develop in AGMex,
we next looked for changes in the biological processes
(GO terms) of the surrounding cells that may form part of
the microenvironment. The OC (Figure 4E) and EC (Fig-
ure 4F) fractions significantly upregulate genes related to
ECM and metabolism in AGMex compared with AGMin.
The immune response GO term is significantly represented
inOCs (Figure 4E) while signaling pathways, development,
andmigrationprocess are upregulated in the EC (Figure 4F).
Thus, a complex microenvironment in AGMex appears to
support the two HSC types early in development.DISCUSSION
We initiated this study to examine the interface of two
developmental signaling pathways in AGM HSCs. Rather
than converging on the sameHSCs, BMP andHh pathwaysrs
Figure 4. Transcriptome Analysis of E11 AGM Cell Fractions
Transcriptional differences between BRE GFP+ and GFP HPSCs (CD31+cKit+) as shown in a pie chart of significantly enriched GO categories
for genes with >2-fold higher FPKMs in HPSC AGMex (A) GFP+ compared with GFP and (B) GFP compared with GFP+.
(C) Gene set enrichment analysis of genes upregulated (>2 fold higher FPKM) in AGMex HPSC GFP+ fraction compared with GFP in which the
same genes are downregulated.
(D) Gene set enrichment analysis of genes with >2-fold upregulated expression in AGMex HPSC GFP fraction and downregulated in the GFP+
fraction. Gene set analysis was performed using the Enrichr web tool. Gene sets significantly enriched in GFP+ (2,229) or GFP (1,876)
(most highly significant gene sets are selected). Shown are transcription factor and drug gene sets with a consistent enrichment pattern,
for which upregulated targets are enriched in one fraction while the downregulated targets are enriched in the opposite fraction.
(E and F) Pie charts of significantly enriched GO and reactome gene categories with >2-fold higher expression in AGMex (E) other cells (OC;
CD31) and (F) endothelial cells (EC, CD31+cKit) compared with the AGMin EC and OC, respectively. In (C) and (D), the Fisher exact test
was performed for each gene set by comparing the number of GFP+ or GFP genes and their overlap to each other. The calculated p values
from Fisher exact tests were corrected for multiple testing using the FDR method. In all other panels, FDR correction for multiple testing
was performed on chi-squared test outcomes from the Enrichr web tool.were found to regulate two distinct HSC types: BMP-acti-
vated and non-BMP-activated Hh/VEGF-responsive HSCs.
The appearance of non-BMP-activated HSCs in this cultureStemsystem was unexpected, since we found the percentage of
BMP-activated cells was increased in AGM explants. It is
likely that the explant culture conditions affect both theCell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The Authors 389
(legend on next page)
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generation and growth of AGM HSCs. The absence of the
tissues surrounding the AGM dorsally and ventrally, such
as the neural tube and gut, respectively, may contribute
to changes in the HSC composition by altering the posi-
tional information. Normally the dorsal microenviron-
ment is restrictive to HSC growth in vivo (Peeters et al.,
2009; Pardanaud and Dieterlen-Lievre, 1999) and its
absence in AGM explants may explain the appearance of
the non-BMP-activated HSC type. Our recent demonstra-
tion of the twoHSC types in the FL (Crisan et al., 2015) sug-
gests that the explant culture of AGM induces a bifurcation
of HSCs into an FL-like state. In the AGM explant, the
non-BMP-activated HSCs are exclusively sensitive to cy-
clopamine treatment and provide no hematopoietic
engraftment upon transplantation, whereas the BMP-acti-
vated HSCs are unaffected. Importantly, HSC activity can
be partially restored in cyclopamine conditions when
VEGF is exogenously added. It would be interesting to
know whether the non-BMP-activated HSCs in the FL are
also controlled by Hh/VEGF signaling, and an appropriate
culture system should be developed to test this. However, it
is known that at E11 both Hh and Gli1 (Cridland et al.,
2009; Hirose et al., 2009) are expressed in the FL, and
thus may influence the second type of HSC in this tissue.
The role of Hh signaling in HSC development is unclear,
and published data regarding this have been in conflict
(reviewed in Lim and Matsui, 2010; Mar et al., 2011). Fifty
percent of germline Ihh/ mouse embryos die at E13.5
from hematological disorders, the stage when HSCs are
highly expanding in the FL microenvironment (reviewed
in Kaimakis et al., 2013). In these mice, erythroid lineage
differentiation is profoundly affected (Cridland et al.,
2009), but surprisingly phenotypic (LSK) HSC numbers
remain unchanged. In contrast, Gli1/ BM LSK HSCs
transplanted into adult recipients show a higher engraft-
ment efficiency compared with wild-type HSCs, and
myeloid development is adversely affected (Merchant
et al., 2010). Both these results could be explained by our
results showing that not all HSCs are regulated by Hh,
and we suggest that BMP-activated HSCs fill in for the
Hh-regulated HSCs in the deficient mice. However, down-
stream of the HSC, Hh is necessary in progenitors and for
erythroid lineage differentiation.
The AGMexplant culture is known to increaseHSC activ-
ity. Whether the increase in AGM explant HSCs is due toFigure 5. Transcriptional Differences between E11 AGM BRE GFP+
(A–C) Expression (FPKMs from RNA sequencing analysis, accession
hematopoietic progenitor/stem cell (HPSC; CD31+cKit+) and end
(A) Hematopoietic transcription factor gene. (B) Hematopoietic mar
(D) Dendrograms showing genetic relationships between HPSCs GFP+
analysis of RNA sequencing datasets.
(E) Sox17 expression in GFP+/ ECs in AGMin and AGMex.
Stemthe expansion and shift in BMP-activation status of exist-
ing HSCs, or the new generation of HSCs (non-BMP-acti-
vated), or both, remains unclear. Secondary transplanta-
tions of GFP+ and GFP BM cells from the primary
recipients who received GFP+ AGM explant cells clearly
demonstrate that BMP-activated AGM cells can give rise
to non-BMP-activated HSCs in the recipient BMmicroenvi-
ronment. However, it is also possible that the non-BMP-
activated HSCs are generated from GFP ECs, which we
found by RNA sequencing to highly express Gli1 after
explant. In aortic clusters, non-BMP-activated hematopoi-
etic cells are found together with BMP-activated hemato-
poietic cells, supporting the notion that heterogeneity of
HSCs can occur at an early developmental stage. However,
our data suggest that the AGMin does not offer the right
microenvironment for the development of the second
HSC type. Only the AGM explant culture model facilitates
study of the two HSC types and their regulation. Others
have shown the existence of pre-HSCs in reaggregate
AGM cultures or in the early FL (Taoudi et al., 2008; Kieus-
seian et al., 2012), and neonatal engrafting HSCs have been
described in the E9 yolk sac (Yoder and Hiatt, 1997). These
may represent the precursors to the non-BMP-activated
(Hh/VEGF-responsive) HSCs. It will be interesting in future
studies to examine these cells and the early hematopoietic
tissues in the context of BMP, as well as Hh signaling
through fate-mapping approaches.
Our RNA sequence datasets show that transcription
factors known to be involved in hematopoietic cell
development are expressed in both the BMP-activated
and non-BMP-activated AGM HPSC fractions, suggesting
that these genes are not exclusively regulated by BMP
signaling. In contrast and importantly, Sox17 a known
target of the BMP signaling pathway (Teo et al., 2012) is
strictly expressed in the BMP-activated HPSC and EC
AGM fractions (Figure 5E). Since Sox17 is required for
endothelial to hematopoietic cell transition and since
all AGM HSCs in vivo are BMP activated (Crisan et al.,
2015), our data suggest that BMP-activated HSCs arise
from BMP-activated ECs. This is further reinforced by
the dendrogram generated from our RNA sequencing
datasets, showing the close relationship of HPSCs to
BMP-activated ECs (Figure 5D).
In conclusion, we show here that the BMP and Hh/
VEGF signaling pathways control two HSC types in theand GFP Cell Types
number GEO: GSE76253) detected in sorted BRE GFP+ and GFP
othelial cell (EC; CD31+cKit) fractions of AGMin and AGMex.
ker gene. (C) Endothelial marker gene expression in HPSC.
/ and ECs GFP+/ in the AGMin and AGMex as measured by cluster
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AGM explant culture. BMP-activated HPSCs differ in their
intrinsic molecular program from the non-BMP-activated
Hh responsive HPSCs, and the molecular program of cells
within the AGM niches changes upon explant, thus impli-
cating the microenvironment in the control of the distinct
HSC types. This knowledge is of high interest to human
health, since Hh antagonists are used today as anti-cancer
and anti-leukemic drugs (Von Hoff et al., 2009; Amakye
et al., 2013). There is a correspondence of drug resistance
in acute myeloid leukemia (AML) patients (Zahreddine
et al., 2014) with high Gli1 expression. Our data also
show that the gene targets of decitabine, a drug used today
to treat patients with myelodysplastic syndrome and AML
(Kantarjian et al., 2003; Kantarjian et al., 2006) are signifi-
cantly upregulated in the BMP-activated HSCs and signifi-
cantly downregulated in the non-BMP-activated HSCs
(Figure 4C), suggesting that the two HSC types do not
respond similarly to drug treatment. Thus, patients may
not respond similarly, or not at all, to certain drug treat-
ments based on the affected HSC type.EXPERIMENTAL PROCEDURES
Mice and Embryo Generation
Mice were bred and housed at Erasmus MC. BRE GFP transgenic
mice (Monteiro et al., 2008) were maintained in C57BL/6 back-
ground.Matings were set up between heterozygous BRE GFP trans-
genic male and non-transgenic wild-type C57BL/66 female mice.
The day of vaginal plug detection was designated as embryonic
day 0. All animal procedures were approved by the Erasmus MC
Ethical Review Board and performed in compliancewith Standards
for Care and Use of Laboratory Animals.
AGM Explant Culture
AGMs were dissected as previously described (Medvinsky and
Dzierzak, 1996; Kumaravelu et al., 2002). They were placed on
a 0.65-mm Durapore filter on a sterile grid in six-well plates at
the gas-liquid interface and cultured with Methocult 5300 or
Stem Span serum-free medium (Stem Cell Technology) with 1%
hydrocortisone (Sigma) and 1% PS, ± BMP4 (20 ng/ml), Shh
(20 ng/ml), VEGF (50 ng/ml), and cyclopamine (Sigma, 5 mM) for
3 days at 37C. Cells were prepared as previously described
(de Bruijn et al., 2002). AGMs were dissociated by incubation in
collagenase type I (0.125% [w/v]; Sigma) diluted in PBS/10%
FCS/1% PS at 37C for 45 min, manually disrupted, and washed,
and viable cells were counted.
Flow Cytometry
AGM cells were stained with anti-CD31PE-Cy7 (eBioscience,
12-0311-82) and cKit APC (Becton Dickinson, 553356) antibodies
and adult hematopoietic cells with anti-CD31PE (BD, 561073),
Ly6cAPC-Cy7 (BD, 560596), CD4PE (BD, 557308), CD8PE (BD,
553032), and B220APC (BD, 553092) antibodies. Wild-type AGM
cells were used as negative control for the BRE GFPAGM cells. Un-
stained and singlemarker stained cells were used to define the gates392 Stem Cell Reports j Vol. 6 j 383–395 j March 8, 2016 j ª2016 The Authofor fluorescence-activated cell sorting (FACS) analysis and cell sort-
ing. Cells were analyzed on a FACSAria SORP or FACSAria III (BD)
with FloJo software. Dead cell exclusion was with Hoechst 33258
(Molecular Probes).
Transplantation Assay
AGM cells were injected intravenously into female wild-type mice
(129SV3 C57BL/6 or C57Bl/6) irradiated with 900 rad (split dose,
137Cs source). 2 3 105 recipient background spleen cells were co-
injected with AGM cells. Unsorted or sorted BM cells from
primary recipients were injected into irradiated secondary recipi-
ents. For details of AGMembryo equivalents/cell numbers injected
and the number of experiments performed, see Table S2. Chime-
rism was quantified by DNA PCR for gfp. DNA normalization
(myoD) and comparison with gfp contribution controls was
performedwith ImageQuant software. See Table S1 for PCR primer
sequences. Mice showing >5% donor chimerism were considered
repopulated.
Whole-Mount Immunostaining
Whole-mount embryo immunostaining was performed as
described previously (Yokomizo and Dzierzak, 2010; Yokomizo
et al., 2011). Embryos were fixed for 20minwith 2%paraformalde-
hyde/PBS at 4C; dehydrated in graded concentrations of
methanol; stained with primary antibodies unconjugated rabbit
anti-GFP (MBL, #598, 1:2000), biotinylated rat anti-CD31 (BD,
553371, 1:500), and subsequently with rat anti-cKit (14-1171-81,
eBioscience; 1:500) in blocking buffer ON at 4C; washed; incu-
bated with secondary antibodies goat anti-rabbit immunoglobulin
G (IgG)-Alexa Fluor488 (Invitrogen, A11008), goat anti-rat IgG-
Alexa Fluor647 (Invitrogen, A21247), and donkey streptavidin-
Cy3 (Jackson ImmunoResearch, 016-160-084); made transparent
in BABB (benzyl alcohol/benzyl benzoate 1:2); and analyzed with
a confocal microscope (Zeiss LSM 510META JNI, Plan-Neofluar
103/0.3, Eppiplan-Neofluar 203/0.50).
Colony-Forming Unit Culture Assay
AGM cells were cultured in semisolid methylcellulose medium
containing stem cell factor (SCF), IL-3, IL-6, Epo (Stem Cell
Technologies), and 1% PS in 35-mm culture dishes at 37C in
a humidified chamber under 5% CO2. Burst forming unit-eryth-
rocyte (BFU-E) and CFU-granulocyte (CFU-G), -macrophage
(CFU-M), -granulocyte-macrophage (CFU-GM), and mixed col-
onies (CFU-GEMM)were distinguished based on theirmorphology
and counted using an invertedmicroscope at day 10 of the culture.
The p values were calculated using the t test.
RNA Preparation, qRT-PCR, and RNA Sequencing
For qRT-PCR, total RNA was extracted using TRIzol Reagent (Invi-
trogen) and quantitated by a NanoDrop 8000 Spectrophotometer
(Thermo Scientific,NanoDropTechnologies) or a 2100 Bioanalyzer
(Agilent Technologies) with RNA 600 Pico chips (Agilent Technol-
ogies). cDNAwas generated using SuperScript II Reverse Transcrip-
tase (Invitrogen), from 1 mg of starting material. qRT-PCR primers
(Table S1) were used with SYBR Green (Invitrogen) and Platinum
Taq DNA Polymerase (Invitrogen), samples run on a CFX96 Real-
Time System C1000 Thermal Cycler (Bio-Rad), and analyzedrs
with Bio-Rad CFX Manager v2.0 software. b-Actin was used as the
internal reference. For RNA sequencing, RNAwas isolated with the
mirVanamiRNA Kit and prepared according to SMARTER protocol
for the Illumina HiSeq2000 sequencer. Sequences were mapped to
the mouse (NCBI37UCSC/mm910) genome and FPKMs were
calculated using Bowtie (v2.2.3), TopHat (v2.0.12), and Cufflinks
(v2.2.1). Differential expression was analyzed using Cuffquant
with fragment-bias and multi-read corrections, and normalized
across all samples using Cuffnorm with geometric library-size
normalization (Trapnell et al., 2013). Difference in expression
was calculated as GFP+ FPKM+1/AGMin FPKM+1 with threshold
of more than 2-fold change. Genes with more than 2-fold higher
or lower expression in each comparison were applied to Enrichr
tool. Enrichr output (and calculated p values from chi-squared
tests) were imported into R and corrected for multiple testing
(FDR), and a threshold of FDR < 0.05was used. Hierarchical cluster-
ings were performed using log10-transformed FPKMs of the top
10%most variable genes in the R statistical package using hclust()
and dist() commands with default parameters. Heatmaps were
generated using the R heatmap.2 package with row-scaling. For
GSEA, ratios were calculated for AGMex HSPC GFP versus GFP+
FPKMs(+1) and used with GSEA (version 2.0.13) pre-ranked
method using default options (Mootha et al., 2003; Subramanian
et al., 2005). RNAseqdata are publicly available at NCBIGEOunder
accession number GEO: GSE76253.
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The RNA sequence data have been deposited in the Gene
Expression Omnibus (NCBI) database with accession code GEO:
GSE76253.
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